The ADCS
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9452 Medical Center Dr Fl 4, La Jolla, C...Phone Number
(858) 246-1333Website
www.adcs.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About The ADCS
ADCS is a major initiative for Alzheimer's disease clinical studies, formed as a cooperative agreement between the National Institute on Aging and the University of California, San Diego. The organization focuses on addressing treatments for cognitive and behavioral symptoms of Alzheimer's disease through various clinical trials, including studies on thiamine and lifestyle interventions. ADCS aims to facilitate the discovery and testing of new drugs for Alzheimer's disease and is part of the Alzheimer's Disease Prevention Initiative. Their intended clients include individuals experiencing early Alzheimer's disease, Mild Cognitive Impairment, and researchers in the field.Explore more
The ADCS Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The ADCS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if The ADCS is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if The ADCS has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on The ADCS recently announced quarterly report
The ADCS, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at The ADCS
Click to see if The ADCS had a recent Job posting/layoffs
Funding: Get notified immidiatlly once The ADCS has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when The ADCS launches new products
Recommended Actions
Find VP level buyers at The ADCS
Find 2 more new buyers
Compare Similar Companies to The ADCS
Compare insights from companies similar to The ADCS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.4M
11-50
Private
-
1992
Dd
Danillo de la PenaDirector, The Pharmaceutical-Sponsored Clinical Research
Company Profile Activity
Activity Insights
The ADCS is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
The ADCS is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about The ADCS.
The ADCS Tech Stack
A closer look at the technologies used by The ADCS
See more technologies
The ADCS News & Media
Burke Neurological Institute Receives a $45 Million NIH Grant
WHITE PLAINS, N.Y.–(BUSINESS WIRE)–The Burke Neurological Institute has received a five year award expected to total $45 million from the National... Read More The post Burke Neurological Institute Receives a $45 Million NIH Grant appeared first on citybiz.Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Clinical Trial
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild cognitive impairment (MCI). This follow-up trial will expand on previous work completed at BNI, suggesting that hAstellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
- iADCs are a next-generation modality for treating cancer and designed to boost anti-cancer activity, offering potential new options for patients who do not respond to existing cancer immunotherapies - - Sutro will receive an upfront payment of US$90 million to develop iADCs for three...Annovis Bio Reports Positive Safety Data from its Phase 2 Alzheimer's Study
Berwyn, Pennsylvania--(Newsfile Corp. - July 20, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, with data from two phase 2 studies showing its lead compound improves cognition in AD patients and motor function in PD patients, today announced that the Data Safety Monitoring Board (DSMB) has reviewed the safety and tolerability d
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding The ADCS
Sign Up For FreeTo access detailed company insights
ADCS is a major initiative for Alzheimer's disease clinical studies, formed as a cooperative agreement between the National Institute on Aging and the University of California, San Diego. The organization focuses on addressing treatments for cognitive and behavioral symptoms of Alzheimer's disease through various clinical trials, including studies... Read More
